Wednesday, April 26, 2023 Daily Archives

Advanced Orthogonal Methods to Fully Characterize Process Host Cell Proteins

by

This webcast features: Jared Isaac, PhD, Associate Director, Chromatography and Mass Spectrometry, Cygnus Technologies. In recent years, we have learned that host cell proteins (HCP) can cause problems with respect to patient safety, drug substance (DS) stability, and DS efficacy. As such, it is more important than ever to fully understand the HCPs in your process. This webcast will focus on using advanced methods of immunoaffinity chromatography and mass spectrometry to fully characterize the host cell protein ELISA as well…

April 26, 2023

Samsung Biologics Q1 driven by full capacity utilization

by

Full utilization across its three plants has enabled the CDMO to report 41% revenue growth in the first quarter, says Samsung Biologics.   For the first quarter 2023, contract development manufacturing organization (CDMO) Samsung Biologics reported total revenues of KRW 720.9 billion ($539 million), a 41% increase year-on-year. Net profit for the first three months were KRW 141.8 billion , a slight decrease on Q1 2022’s KRW 146.9 billion, attributed to “the elimination of intercompany transactions” after the acquisition of…

April 26, 2023

Maxion awarded grant to advance antibody platform

by

Maxion Therapeutics has been awarded £2 million ($2.4 million) from Innovate UK to develop ion channel antibodies for autoimmune diseases. The grant from Innovate UK is part of its £25 million ($31 million) Biomedical Catalyst fund, which aims to support UK-registered businesses to advance solutions to address health and healthcare challenges. Maxion, a Cambridge, UK based firm, will use the funding to support and develop its KnotBody platform for autoimmune diseases with high unmet clinical need. “KnotBody platform utilizes a…

April 26, 2023

Industry still a slave to single source supply, say experts

by

Despite COVID-19 highlighting supply chain issues, biomanufacturers are still using single sources, say experts at BPI West. In the early stages of the COVID-19 pandemic, single-use bioprocess systems and materials were highlighted as necessary tools in the development and commercial manufacture of potential vaccines and therapies. Said materials and equipment were already in high demand throughout the sector, but the pandemic placed further pressure on raw material and bioprocess equipment supply, with lead times for some single-use components equating to a…

April 26, 2023

Ghanaian consortium to build manufacturing plant

by

President Nana Addo Dankwa Afkufo-Addo has announced the construction of Ghana’s first vaccine manufacturing facility.   Ghana is set to begin construction of its first manufacturing plant this July, with the expectation to be fully operational by January 2024. Under DEKs Vaccine Ltd, a private sector-led consortium of local Ghanaian pharmaceutical firms, the facility will be a fill/finish site, responsible for producing vaccines for rotavirus, cholera, malaria, and pneumonia. It will primarily manufacture malaria vaccines and import COVID components to…

April 26, 2023